In 2017 AddLife enjoyed yet another successful year. Our growth journey continued and our subsidiaries gained additional market share. Three acquisitions were completed that are expected to contribute about SEK 225 million in annual sales. In the later part of the year we focused on streamlining our group and integrating completed acquisitions to strengthen our base for future growth.
Labtech offers products and services to diagnostics and biomedical research and laboratory analysis.
MORE ABOUT LABTECHMedtech offers medical device products to the publicly funded health care.
MORE ABOUT MEDTECHWe develop your company through active ownership. AddLife acquires companies in order to maintain and further develop them in the long term.
MORE ABOUT AQUISITIONSThe Nordic countries, AddLife’s home market, have a growing and aging population, which increases the need for health care and social services. Constructive collaboration between society, research and business is therefore important to meet the expectations of citizens. AddLife actively contributes with its high-quality laboratory and medical technology.
AddLife´s business concept is to add value to customers within healthcare, laboratories and research. We shall achieve this by offering cost efficient high quality products and solutions combined with qualified advisory services to the private and public sector in the Nordics
MORE ABOUT ADDLIFE
